We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
4.00 | 29.09% | 17.75 | 17.00 | 18.50 | 18.25 | 15.25 | 16.25 | 7,554,983 | 16:29:58 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 1.04M | -21.69M | -0.0832 | -2.13 | 46.25M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/10/2022 18:37 | Refer to my previous post !!!U r a fraud ....Sussed you .... | amaretto1 | |
11/10/2022 18:35 | Are you being obtuse? The could be said if you had breakthroughs at Imperial College or Cambridge Uni. This is a commercial operation ffs - AN has to monetise the bloody system! That is what the market considers as delivery having poured millions into the company over the years. | fevertreeman | |
11/10/2022 18:31 | Beckman Coulter !!! Never mind ... UK.... NHS are going down the diagnostic path !!Check this avenue out ... No idea how that will work like | amaretto1 | |
11/10/2022 18:29 | We just attracted the biggest diagnostic company in America ... in Chicago... | amaretto1 | |
11/10/2022 18:27 | Concrete delivery ????We just got FDA clearance.....Breast .... ovarian results ... God knows what else in the background.....More i read your posts .. the more i had | amaretto1 | |
11/10/2022 18:25 | So with all this knowledge...Why are you holding ? Polite question. | amaretto1 | |
11/10/2022 18:23 | With respect, the market is agnostic. What the share price is telling us is that (1) impossible to value this company in the absence of cashflows (2) management is thin (3) market lacks patience (4) in a bear market long duration assets (i.e. unprofitable) companies like Angle are only valued on conctrete delivery. | fevertreeman | |
11/10/2022 18:15 | I've no idea why SK is allowing you on this board ...You have one objective and that's to wind up serious posters on here. None of the long term holders give one jot the short term share price ...i for one covet it going lower ...I've been adding every day under 70 ! As for you ...go to a Dr tommorow and seek help you sick individual. SK ??? | amaretto1 | |
11/10/2022 17:44 | 60p resistance now broken so this will now slide out of control in the absence of positive news or deals. I suggested 50p soon but can see it sliding lower before the year is out unless AN decides shareholder value is important and gets someone capable to run the business side. On a side note, the serial rampers with their own agendas should be removed from this board as a matter of urgency. | antonagis | |
11/10/2022 17:38 | @Fevertreeman ... Abbott will demand exclusivity. AN, given his philanthropic tendencies and general outlook, will never offer that. So, to get exclusivity, Abbott will likely have to buy the company. I think there is a good chance that any take-over offer by Abbott will lead to a bidding war ... with exclusivity the prize. AN will not have much/any control over how this would all pan out ... and he would probably not be able to realize his philanthropic ambitions. But it could work out very well for holders. AN lacking the basic motivation to cut a deal that best serves shareholder interests is a real concern, however, especially in the context of wider governance concerns (all far too cosy imho). I am coming round to the view that a mangement shake-up really is necessary. | saltraider | |
11/10/2022 16:44 | Walked down all day ....Then guess what .. the big scoop at the end ..... so predictable!!I'll have more tomorrow...,thankyou | amaretto1 | |
11/10/2022 16:39 | Why you trying to kid yourself ...We all know what AGL are sat on ..It's groundbreaking technology..We all know this ...Imo NHS door as opened as well !!! | amaretto1 | |
11/10/2022 16:36 | Your a bizzare character....You have just seen illumina buy grail ... for 7b ...What's AGL worth ? Definitely more than this mkt cap FACT | amaretto1 | |
11/10/2022 16:33 | Why you holding then ? Same old rhetoric... u a gluten for punishment...Just sell ... it's that simple | amaretto1 | |
11/10/2022 16:31 | This industry is all about talking. If I had a dollar for every pharma/biotech CEO at US investor conferences I've attended over the years whose pitch consisted of "we have an amazing prduct/product line & we are in discussions with numerous major international players" I'd be an extremely rich man. The point here is that AN isnt giving shareholders any milestones to hang investment decisions on. It is more a case of "Trust me, I know what I'm doing!". I am sure that the hard-nosed execs at Abbott are very happy to continue talking with AN , knowing that time is on their side and that by playing the long game they are likely to license in/pick the company up for a song. AN has little or no power in the negotiations unless he can create competitive tension - with players willing to acquire/sign licensing deals for the parsortix system. And therein lies his probelm ; Abbott will want exclusivity & AN talks about doing multiple deals... | fevertreeman | |
11/10/2022 16:29 | https://news.sky.com | 1liam | |
11/10/2022 16:21 | Buy at 30p | 1liam | |
11/10/2022 16:17 | And we are definitely talking to Abbot.... That's a fact !!!Imo talks are concluding sooner than we think ... that's why the shakeout we are seeing with share price !! I'm just adding every day around hereLower the better for me ...I believe !!! So do all analysts !! | amaretto1 | |
11/10/2022 16:14 | i get your point ... he's a clever cookie no doubt about that ..Maybe we have the partner takeover sighn up ...Abbot talks could be just that ... | amaretto1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions